BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12050728)

  • 1. [Progress in the treatment of non-Hodgkin's lymphomas].
    Varga F; Demeter J
    Magy Onkol; 2001; 45(1):45-50. PubMed ID: 12050728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of advanced non-Hodgkin's lymphoma in adults.
    Friedenberg WR
    Wis Med J; 1991 Dec; 90(12):676-8. PubMed ID: 1843059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practice guidelines for the management of extranodal non-Hodgkin's lymphomas of adult non-immunodeficient patients. Part I: primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
    Zinzani PL; Martelli M; Poletti V; Vitolo U; Gobbi PG; Chisesi T; Barosi G; Ferreri AJ; Marchetti M; Pimpinelli N; Tura S; ; ;
    Haematologica; 2008 Sep; 93(9):1364-71. PubMed ID: 18603558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Medicinal therapy of malignant lymphomas].
    Aul C; Schroeder M; Giagounidis A
    Radiologe; 2002 Dec; 42(12):943-53. PubMed ID: 12486548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purine Analogs for the Treatment of Low-Grade Lymphoproliferative Disorders.
    Fidias P; Chabner BA; Grossbard ML
    Oncologist; 1996; 1(3):125-139. PubMed ID: 10387979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced intensity allogeneic stem cell transplantation for low grade non-Hodgkin's lymphoma.
    Morris EC; Mackinnon S
    Best Pract Res Clin Haematol; 2005 Mar; 18(1):129-42. PubMed ID: 15694189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical practice guidelines: non-Hodgkin's lymphomas.
    Fisher RI; Oken MM
    Cleve Clin J Med; 1995; 62 Suppl 1():SI6-42, quiz SI43-5. PubMed ID: 7641398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives on purine analogues.
    Cheson BD
    Hematol Cell Ther; 1996 Dec; 38 Suppl 2():S109-16. PubMed ID: 9137964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab plus ASHAP for the treatment of patients with relapsed or refractory aggressive non-Hodgkin's lymphoma: a single-centre study of 20 patients.
    Aydin S; Dührsen U; Nückel H
    Ann Hematol; 2007 Apr; 86(4):271-6. PubMed ID: 17216473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation therapy for localized low-grade non-Hodgkin's lymphomas.
    Tsang RW; Gospodarowicz MK
    Hematol Oncol; 2005 Mar; 23(1):10-7. PubMed ID: 16158458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.
    Peniket AJ; Ruiz de Elvira MC; Taghipour G; Cordonnier C; Gluckman E; de Witte T; Santini G; Blaise D; Greinix H; Ferrant A; Cornelissen J; Schmitz N; Goldstone AH;
    Bone Marrow Transplant; 2003 Apr; 31(8):667-78. PubMed ID: 12692607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune thrombocytopenia in non-Hodgkin's lymphomas.
    Hauswirth AW; Skrabs C; Schützinger C; Raderer M; Chott A; Valent P; Lechner K; Jäger U
    Haematologica; 2008 Mar; 93(3):447-50. PubMed ID: 18287133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxaliplatin/rituximab combination in the treatment of intermediate-low grade non-Hodgkin's lymphoma of elderly patients.
    Addeo R; Caraglia M; Costanzo R; Faiola V; Montella L; Abbruzzese A; Del Prete S
    Oncol Rep; 2004 Jul; 12(1):135-40. PubMed ID: 15201974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
    Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD45 expression in low-grade B-cell non-Hodgkin's lymphomas.
    Carulli G; Cannizzo E; Zucca A; Buda G; Orciuolo E; Marini A; Petrini M
    Leuk Res; 2008 Feb; 32(2):263-7. PubMed ID: 17692374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of non-Hodgkin's lymphoma: biology, staging, and treatment.
    Fisher RI
    Semin Oncol; 2003 Apr; 30(2 Suppl 4):3-9. PubMed ID: 12728402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the anti-CD20 antibody rituximab in hematopoietic stem cell transplantation for non-Hodgkin's lymphoma.
    Naparstek E
    Curr Hematol Rep; 2005 Jul; 4(4):276-83. PubMed ID: 16009042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Follicular lymphoma].
    Illés A; Krenács L; Borbényi Z
    Orv Hetil; 2003 Nov; 144(46):2253-61. PubMed ID: 14702920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic transplantation in lymphoma: current status.
    Schmitz N; Dreger P; Glass B; Sureda A
    Haematologica; 2007 Nov; 92(11):1533-48. PubMed ID: 18024402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of allogeneic transplantation in low-grade lymphoma and chronic lymphocytic leukemia.
    Thomson KJ; Mackinnon S
    Curr Opin Hematol; 2006 Jul; 13(4):273-9. PubMed ID: 16755225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.